ripekg:evaluation/RIPEA0A4B2238CEE31171 |
prov:used |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA0A4B2238CEE31171 |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA0A4B2238CEE31171 |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2025-084314Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
ripe:recruitmentEndDateExtractionRationale |
No explicit last patient in date found. |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
ripe:recruitmentStartDate |
16-01-2024 |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
ripe:recruitmentStartDateExtractionRationale |
Setting: 'Five hospitals in China, 16 January to 11 June 2024.' indicates the recruitment start date. |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
ripe:studyEndDate |
11-06-2024 |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
ripe:studyEndDateExtractionRationale |
Setting: 'Five hospitals in China, 16 January to 11 June 2024.' indicates the study end date. |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA0A4B2238CEE31171-human-2-2 |
ripekg:study-design-evidence/RIPEA0A4B2238CEE31171 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA0A4B2238CEE31171-inspectai-2-2 |